Commonwealth Equity Services’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92K | Sell |
53,693
-1,765
| -3% | -$3.02K | ﹤0.01% | 4077 |
|
|
2025
Q1 | $185K | Buy |
55,458
+23,944
| +76% | +$79.9K | ﹤0.01% | 3868 |
|
|
2024
Q4 | $233K | Buy |
31,514
+16,113
| +105% | +$119K | ﹤0.01% | 3632 |
|
|
2024
Q3 | $145K | Buy |
15,401
+1,996
| +15% | +$18.8K | ﹤0.01% | 3801 |
|
|
2024
Q2 | $108K | Buy |
13,405
+3,133
| +31% | +$25.2K | ﹤0.01% | 3796 |
|
|
2024
Q1 | $152K | Buy |
+10,272
| New | +$152K | ﹤0.01% | 3706 |
|
|
2021
Q4 | – | Sell |
-9,491
| Closed | -$234K | – | 3692 |
|
|
2021
Q3 | $234K | Sell |
9,491
-511
| -5% | -$12.6K | ﹤0.01% | 3145 |
|
|
2021
Q2 | $260K | Buy |
10,002
+2,992
| +43% | +$77.8K | ﹤0.01% | 3038 |
|
|
2021
Q1 | $221K | Buy |
7,010
+1,565
| +29% | +$49.3K | ﹤0.01% | 3054 |
|
|
2020
Q4 | $252K | Buy |
+5,445
| New | +$252K | ﹤0.01% | 2724 |
|